Literature DB >> 207653

Distribution of 18F-5-fluorouracil in tumor-bearing mice and rats.

J Shani, W Wolf, T Schlesinger, H L Atkins, P R Bradley-Moore, V Casella, J S Fowler, D Greenberg, T Ido, R M Lambrecht, R MacGregor, C Mantescu, R Neirinckx, P Som, A P Wolf, I Wodinsky, K Meaney.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 207653     DOI： 10.1016/0047-0740(78)90086-4

Source DB:  PubMed          Journal:  Int J Nucl Med Biol        ISSN： 0047-0740


× No keyword cloud information.
  9 in total

1.  Tissue distribution of [18F]-5-fluorouracil in mice: effects of route of administration, strain, tumour and dose.

Authors:  G W Visser; G C Gorree; G J Peters; J D Herscheid
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

Review 2.  Cellular pharmacology of fluorinated pyrimidines in vivo in man.

Authors:  J S Kovach; R W Beart
Journal:  Invest New Drugs       Date:  1989-04       Impact factor: 3.850

Review 3.  Fluorinated tracers for imaging cancer with positron emission tomography.

Authors:  Olivier Couturier; André Luxen; Jean-François Chatal; Jean-Philippe Vuillez; Pierre Rigo; Roland Hustinx
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-07-06       Impact factor: 9.236

4.  Studies on 18F-labeled pyrimidines. II. Metabolic investigation of 18F-5-fluorouracil, 18F-5-fluoro-2'-deoxyuridine and 18F-5-fluorouridine in rats.

Authors:  K Ishiwata; T Ido; K Kawashima; M Murakami; T Takahashi
Journal:  Eur J Nucl Med       Date:  1984

5.  An optimized synthesis of 18F-labelled 5-fluorouracil and a reevaluation of its use as a prognostic agent.

Authors:  G W Visser; G C Gorree; B J Braakhuis; J D Herscheid
Journal:  Eur J Nucl Med       Date:  1989

6.  Metabolic changes of glioma following chemotherapy: an experimental study using four PET tracers.

Authors:  K Sato; M Kameyama; K Ishiwata; R Katakura; T Yoshimoto
Journal:  J Neurooncol       Date:  1992-09       Impact factor: 4.130

7.  Studies on 18F-labeled pyrimidines. Tumor uptakes of 18F-5-fluorouracil, 18F-5-fluorouridine, and 18F-5-fluorodeoxyuridine in animals.

Authors:  Y Abe; H Fukuda; K Ishiwata; S Yoshioka; K Yamada; S Endo; K Kubota; T Sato; T Matsuzawa; T Takahashi; T Ido
Journal:  Eur J Nucl Med       Date:  1983

8.  Studies on 18F-labeled pyrimidines III. Biochemical investigation of 18F-labeled pyrimidines and comparison with 3H-deoxythymidine in tumor-bearing rats and mice.

Authors:  K Ishiwata; T Ido; Y Abe; T Matsuzawa; M Murakami
Journal:  Eur J Nucl Med       Date:  1985

9.  Prolonged retention of high concentrations of 5-fluorouracil in human and murine tumors as compared with plasma.

Authors:  G J Peters; J Lankelma; R M Kok; P Noordhuis; C J van Groeningen; C L van der Wilt; S Meyer; H M Pinedo
Journal:  Cancer Chemother Pharmacol       Date:  1993       Impact factor: 3.333
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.